|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Improved gas exchange has been observed during spontaneous
breathing with airway pressure release ventilation (APRV) as compared with controlled mechanical ventilation. This study was designed to determine whether use of APRV with spontaneous
breathing as a primary ventilatory support modality better prevents deterioration of cardiopulmonary function than does initial
controlled mechanical ventilation in patients at risk for acute respiratory distress syndrome (ARDS). Thirty patients with multiple
trauma were randomly assigned to either breathe spontaneously
with APRV (APRV Group) (n = 15) or to receive pressure-controlled, time-cycled mechanical ventilation (PCV) for 72 h followed
by weaning with APRV (PCV Group) (n = 15). Patients maintained
spontaneous breathing during APRV with continuous infusion of
sufentanil and midazolam (Ramsay sedation score [RSS] of 3). Absence of spontaneous breathing (PCV Group) was induced with
sufentanil and midazolam (RSS of 5) and neuromuscular blockade.
Primary use of APRV was associated with increases (p < 0.05) in
respiratory system compliance (CRS), arterial oxygen tension (PaO2),
cardiac index (CI), and oxygen delivery (DO2), and with reductions
(p < 0.05) in venous admixture (
VA/
T), and oxygen extraction.
In contrast, patients who received 72 h of PCV had lower CRS, PaO2,
CI, DO2, and
VA/
T values (p < 0.05) and required higher doses
of sufentanil (p < 0.05), midazolam (p < 0.05), noradrenalin (p < 0.05), and dobutamine (p < 0.05). CRS, PaO2, CI and DO2 were lowest (p < 0.05) and
VA/
T was highest (p < 0.05) during PCV. Primary use of APRV was consistently associated with a shorter duration of ventilatory support (APRV Group: 15 ± 2 d [mean ± SEM];
PCV Group: 21 ± 2 d) (p < 0.05) and length of intensive care unit
(ICU) stay (APRV Group: 23 ± 2 d; PCV Group: 30 ± 2 d) (p < 0.05). These findings indicate that maintaining spontaneous
breathing during APRV requires less sedation and improves cardiopulmonary function, presumably by recruiting nonventilated
lung units, requiring a shorter duration of ventilatory support and
ICU stay.
| |
INTRODUCTION |
|---|
|
|
|---|
Acute respiratory distress syndrome (ARDS) causes alveolar
collapse primarily in dependent lung regions adjacent to the diaphragm, resulting in intrapulmonary venous admixture of blood
(
VA/
T) and severe arterial hypoxemia (1). Mechanical ventilation with positive end-expiratory pressure (PEEP) and low
tidal volume (VT) is commonly applied during ARDS to recruit collapsed alveoli for gas exchange without hyperinflation
of the lungs (2, 3). Despite early mechanical ventilation with
PEEP, a high number of patients at risk have been observed
to develop ARDS (4).
An improvement in ventilation-perfusion (
A/
) matching
has been considered an advantage of partial ventilatory support as compared with controlled mechanical ventilation (5),
presumably because the diaphragmatic contraction augments
distribution of ventilation to dependent, poorly aerated but perfused lung regions (8). Spontaneous breathing in any phase of
the mechanical ventilator cycle is possible with airway pressure
release ventilation (APRV), which ventilates by periodic
switching between two levels of continuous positive airway
pressure (CPAP) (9, 10). Recently, we observed that patients
with severe ARDS exhibited better
A/
matching and arterial oxygenation, during spontaneous breathing with APRV than during controlled mechanical ventilation (11). However, it is not known whether maintaining spontaneous breathing
from the very beginning of ventilatory support may prevent
alveolar collapse and thereby reduce
VA/
T and hypoxemia
in patients at risk for ARDS.
We hypothesized that in patients at risk for ARDS, spontaneous breathing with APRV prevents deterioration of gas exchange or allows it to recover faster than does controlled mechanical ventilation. To test this hypothesis, we examined cardiopulmonary function in patients with severe multiple trauma who were either allowed to breathe spontaneously during APRV or were given full ventilatory support for 72 h and then weaned with APRV.
| |
METHODS |
|---|
|
|
|---|
The study protocol was approved by the Innsbruck Ethics Committee. In accordance with Austrian federal law, the independent Innsbruck Ethics Committee waived the need for informed consent by the patients in the study, given that all were unconscious and approved ventilatory modalities were used.
Thirty mechanically ventilated patients with severe multiple trauma, as indicated by an injury severity score (ISS) (12) above 40, were studied. Patients were not included in the study if they had chronic lung or heart disease, bronchopleural fistula, or severe cerebral injury. The criteria of the American-European Consensus Conference were used to define acute lung injury (ALI) and ARDS (13). Sepsis was defined by the criteria of the American College of Chest Physician and the Society of Critical Care Medicine Consensus Conference Committee of 1992 (14). Organ failure was defined with the scoring system described by Knaus and colleagues (15). Severity of illness was assessed with the Simplified Acute Physiologic Score (16).
Routine clinical management of the patients included the use of a radial artery catheter and a thermistor-tipped quadruple-lumen pulmonary artery catheter (CCO 746HF8; Baxter Edwards Critical Care, Irvine, CA).
Cardiovascular Measurements
Heart rate (HR) was obtained from the electrocardiogram. Systemic blood pressure (Psa), central venous pressure (Pcv), pulmonary artery pressure (Ppa), and pulmonary artery occlusion pressure (Ppao) were transduced (P50; Gould, Oxnard, CA) and recorded. Cardiac output (CO) was continuously estimated with the thermal dilution technique (Vigilance; Baxter Edwards Critical Care, Irvine, CA). In addition, intermittent determinations of CO were made with 10 ml of iced 0.9% saline solution as indicator and by averaging seven determinations made at random moments during the ventilatory cycle.
Ventilatory and Lung Mechanics Measurements
Gas flow and airway pressure were measured at the proximal end of the tracheal tube with a heated pneumotachograph (No. 2; Fleisch, Lausanne, Switzerland) connected to a differential pressure transducer (P130; Statham, Oxnard, CA). VT was derived from the integrated gas flow signal. End-inspiratory pressures were measured after a 5-s end-inspiratory occlusion, and intrinsic positive end-expiratory pressures (PEEPi) were measured after a 5-s end-expiratory occlusion of the airway as described previously (17). Respiratory system compliance (CRS) was obtained during transient neuromuscular blockade with intravenous vecuronium bromide in a dose of 0.1 mg/kg by dividing expiratory VT by the difference between end-inspiratory Paw and PEEPi. A static pressure-volume (P-V) curve of the total respiratory system was constructed on a daily basis for each patient during transient neuromuscular blockade (18, 19). The lower inflection pressure (LIP) was defined as the lowest and the upper inflection pressure (UIP) as the highest Paw at which the slope of the static inflation P-V curve was maximal (18, 19). A computerized step-by-step regression analysis was used to quantify LIP and UIP as described previously (20).
Gas Analysis
Arterial and mixed venous blood gases (oxygen tension [PO2], and carbon dioxide tension [PCO2]) and pH were determined in duplicate, immediately after sampling, with standard blood gas electrodes (STAT5Profil; Nova Biomedical, Waltham, MA). Each sample had oxygen saturation and hemoglobin analyzed spectrophotometrically (OSM3; Radiometer, Copenhagen, Denmark). Fractions of inspired and expired O2 and CO2 (FIO2 and FEO2, and FICO2 and FECO2, respectively) were continuously measured (Deltatrac; Datex, Helsinki, Finland).
Data Analysis
Standard formulas were used to calculate cardiac index (CI), systemic
vascular resistance (SVR),
VA/
T, oxygen delivery (DO2), and oxygen extraction ratio (O2ER). Oxygen consumption (
O2) was calculated as (VI·FIO2)
(VE · FEO2).
Protocol
After inclusion in the study, all patients remained supine. Adequate
fluid supply was ensured with infusion of lactated Ringer's solution to
achieve a Ppao of 14 to 18 mm Hg. Albumin 5% solution was given to
maintain serum albumin concentrations above 2.0 g/dl, and packed
red blood cells were given to achieve a hemoglobin of at least 10 g/dl.
Dobutamine was infused when, despite fluid replacement, CI fell below 3.0 L/min/m2, and was given to achieve a CI of 3.5 to 4.0 L/min/m2.
Norepinephrine infusion was added if SVR was below 600 dyn · s/
cm
5, to restore a mean Psa of 70 to 80 mm Hg. In the presence of oliguria, dopamine infusion was added at a fixed rate of 3 µg/kg/min.
Pressure-limited ventilatory support was provided with the demand-valve CPAP circuit of a standard ventilator (Evita; Dräger, Lübeck, Germany). The low pressure level was set at 2 cm H2O above LIP on a static P-V curve, and the upper pressure level was adjusted to the value below UIP that produced a VT of less than 7 ml/kg during transient neuromuscular blockade. Airway pressure limits were readjusted on a daily basis according to the P-V curve. The ventilator rate was set to maintain PaCO2 at 45 to 55 mm Hg. The duration of the upper and lower pressure levels was always adjusted to allow flow to decelerate to zero, and the resulting inspiratory-to-expiratory ratio was kept constant. FIO2 was adjusted to maintain PaO2 above 60 mm Hg.
After obtaining baseline measurements, we randomly assigned patients to receive APRV with spontaneous breathing (APRV Group) or pressure-limited, time-cycled, controlled mechanical ventilation (PCV) for 72 h followed by weaning with APRV (PCV Group). Note that from a mechanical standpoint, APRV without spontaneous breathing was identical to PCV. In the APRV Group, all patients maintained spontaneous breathing during ventilatory support with continuous infusion of sufentanil and midazolam as required to achieve a Ramsay sedation score (RSS) of 3 (21). To assess cardiopulmonary function during APRV in the absence of spontaneous breathing, we gave patients in the PCV Group continuous infusions of sufentanil and midazolam as required to achieve an RSS of 5 to 6, and paralyzed them with intravenous vecuronium bromide at 0.1 mg/kg for 72 h. Neuromuscular blockade was considered sufficient with disappearance of the twitch response to a train of four supramaximal ulnar nerve stimulations at 2.0 Hz for 1.5 s every 2 min (Myograph 2000; Organon Teknika, Boxtel, The Netherlands). Then, in patients of the PCV Group, infusion of midazolam and sufentanil was reduced to achieve an RSS of 3, and spontaneous breathing was allowed with APRV.
All patients were weaned according to a strict protocol by decreasing the APRV rate twice daily. Clinical tolerance of weaning was considered poor and ventilatory support was increased when patients developed a respiratory rate > 35 breaths/min, pH < 7.25, SaO2 < 90%, HR > 140 beats/min or a sustained increase or decrease in HR of more than 20%, systolic Psa > 180 mm Hg or < 90 mm Hg, increased accessory muscle activity, diaphoresis, and facial signs of distress (22). Patients were extubated when they breathed comfortably with 5 cm H2O CPAP for 6 h.
Measurements including arterial blood gas analysis and data collection were made under stable conditions as confirmed by constancy (± 5%) of
E, SaO2, FECO2, Psa, Ppao, and CI for at least 30 min at 8-h
intervals over a period of 10 d. Cardiopulmonary variables were averaged for each 24-h period.
Endpoints and Statistical Analysis
The primary endpoints of the study were the effects of primarily partial ventilatory support on cardiorespiratory function within 10 d after ICU admission. The secondary endpoints were duration of ventilatory support, intubation, and ICU stay.
Results are expressed as mean ± SEM. Data were tested for normal distribution with the Shapiro-Wilks W test and were analyzed by two-way analysis of variance (ANOVA), with the initial ventilatory modality as the between-group factor and time after randomization as the repeated-measures factor. When a significant F ratio was obtained, differences between the means were isolated with the post hoc Newman-Keuls multiple comparison test. Clinical characteristics of the two groups were compared through a one-way ANOVA. Differences were considered statistically significant if p < 0.05.
| |
RESULTS |
|---|
|
|
|---|
There were no statistically significant differences between the two study groups in their demographic (Table 1) or clinical data (Figures 1-4) at baseline.
|
|
|
|
|
In all patients, LIP and UIP could be identified on the static
P-V curve (Figure 1). Ventilatory variables, ventilator settings, and lung mechanics are shown in Figure 2. Patients were initially mechanically ventilated with an essentially identical low
Paw limit (APRV Group: 12 ± 1 cm H2O; PCV Group: 12 ± 1 cm H2O), upper Paw limit (APRV Group: 26 ± 1 cm H2O;
PCV Group: 26 ± 1 cm H2O), and ventilatory rate (APRV
Group: 16 ± 2 breaths/min; PCV Group: 16 ± 2 breaths/min),
resulting in similar values of
E (APRV Group: 9.9 ± 0.4 L;
PCV Group: 10.2 ± 0.3 L) and CRS (APRV Group: 40 ± 3 ml/
cm H2O; PCV Group: 40 ± 2 ml/cm H2O). In the APRV
Group, a lower upper limit of Paw and ventilatory rate (p < 0.05) and an unchanged lower limit of Paw resulted in an essentially equal total
E and a higher compliance (p < 0.05)
than in the PCV group. The highest upper Paw limit (p < 0.05) and lowest compliance (p < 0.05) were observed in the
absence of spontaneous breathing. When patients in the PCV
group were switched to APRV with spontaneous breathing after the initial 72-h period, the upper Paw limit and ventilatory
rate could be reduced (p < 0.05), whereas total
E remained
unchanged and CRS increased (p < 0.05). In the APRV-group, spontaneous breathing during APRV accounted for 10 ± 2%
of the total
E on Day 1, which increased to 35 ± 9% by Day
10 (p < 0.05). In the PCV Group, spontaneous breathing began by accounting for 8 ± 2% of total
E on Day 4, which increased to 20 ± 3% by Day 10 (p < 0.05). Spontaneous
E
and respiratory rate were always higher in the APRV Group
than in the PCV Group (p < 0.05). PEEPi and VT were not
significantly different for the two groups.
Changes in cardiovascular variables are shown in Figure 3. CI was higher (p < 0.05) and SVR and PVR lower (p < 0.05) in the APRV Group than in the PCV Group. CI was lowest in the absence of spontaneous breathing (p < 0.05). When spontaneous breathing was allowed during APRV on Day 4 in the PCV Group, CI increased (p < 0.05). HR, Psa, Pcv, Ppa, and Ppao were not significantly different in the two groups.
Maintaining spontaneous breathing with APRV was associated with a lower
VA/
T (p < 0.05) and a higher PaO2/FIO2
(p < 0.05) and DO2 (p < 0.05) than was seen in the PCV Group
(Figure 4). Despite spontaneous breathing in the APRV
Group,
O2 was comparable to that of patients receiving full
ventilatory support, and O2ER was lower (p < 0.05). PaO2/FIO2
(p < 0.05) and DO2 (p < 0.05) were lowest and
VA/
T was
highest in the absence of spontaneous breathing (p < 0.05).
Arterial pH, PaCO2, SaO2, SvO2, and
O2 were comparable in
the two groups.
Less sufentanil (p < 0.05) and midazolam (p < 0.05) was administered to patients breathing spontaneously with APRV than to patients receiving full ventilatory support in the initial 72 h (Figure 5). The highest doses of sufentanil and midazolam were required to adapt patients to controlled mechanical ventilation during the first 3 d in the PCV Group (p < 0.05). Similarly, less noradrenaline (p < 0.05) and dobutamine (p < 0.05) were required to achieve the desired cardiovascular function in the APRV Group.
|
The incidence of ARDS was highest in the the PCV Group within the first 10 d after admission to the ICU. In contrast, the incidence of ALI was higher in patients who from the beginning breathed spontaneously with APRV. Durations of ventilatory support (p < 0.05), intubation (p < 0.05), and ICU stay (p < 0.05) were shorter in patients in whom spontaneous breathing with APRV was used as the primary ventilatory modality (Table 2).
|
| |
DISCUSSION |
|---|
|
|
|---|
This study was designed to evaluate the effect of spontaneous
breathing with APRV on gas exchange and cardiovascular
function in patients at risk for ARDS. When spontaneous
breathing was allowed from the beginning of ventilatory support, gas exchange improved, as reflected by a higher PaO2/FIO2
ratio and lower
VA/
T. The concomitant increase in CI and
arterial oxygenation improved the relationship between tissue
oxygen supply and demand;
O2 remained unchanged despite
the work of spontaneous breathing. In contrast, controlled mechanical ventilation for 72 h followed by weaning with APRV
effected slower improvement in cardiopulmonary function and was associated with an increased duration of ventilatory
support and stay in the ICU.
Patients with multiple trauma are considered at risk for development of ARDS. Hudson and coworkers (4) observed a
50% incidence of ARDS in trauma victims with an ISS above
50. The high incidence of ALI and ARDS in our trauma patients, who had an average ISS of 50, is in agreement with
these findings. Controlled mechanical ventilation has been
claimed superior to unsupported spontaneous breathing in the
prevention of severe pulmonary dysfunction and arterial hypoxemia following trauma (23). On the other hand, arterial
hypoxemia caused by
VA/
T during ARDS has been found to correlate directly with the quantity of nonaerated tissue observed by computed tomography in dependent lung regions
adjacent to the diaphragm. These observations have been attributed to alveolar collapse caused by the superimposed pressure on the lung and a cephalad shift of the diaphragm most
evident in dependent lung areas during mechanical ventilation
(1). Persisting spontaneous breathing during ventilatory support has been considered to improve both the distribution of
ventilation to dependent lung areas and gas exchange, presumably by diaphragmatic contraction opposing alveolar compression (8, 11). This may explain why our patients, during full
ventilatory support, had a lower PaO2/FIO2 ratio and thereby
fulfilled the criteria for ARDS. However, ALI and ARDS only represent different levels of pulmonary gas exchange disturbance caused by the same inflammatory reaction leading to
increased vascular and alveolar permeability, interstitial edema
formation, and alveolar collapse (13).
Partial ventilatory support is used increasingly, not only to
wean patients from mechanical ventilation, but to provide stable ventilatory assistance of a desired degree during ventilatory failure (11, 24). Spontaneous breathing in any phase of the mechanical ventilator cycle is possible with APRV that provides ventilatory support by time-cycled switching between two levels of CPAP (9, 10). When spontaneous breathing is abolished, APRV is not different from conventional PCV (9). Ventilatory support during APRV is determined by pulmonary mechanics, ventilatory rate, and the degree of spontaneous breathing. Consequently, in the absence of spontaneous breathing
during APRV, lower alveolar ventilation results in a high PaCO2
and low pH unless the airway pressure limits are adjusted to
produce a larger VT and acceptable PaCO2 and pH. Therefore,
to maintain,
E, PaCO2, and pH in the absence of spontaneous
breathing, the pressure support level had to be significantly increased, and to prevent upper airway pressure from exceeding
UIP, the ventilatory rate had to be significantly increased. Primarily partial ventilatory support with APRV allowed earlier
discontinuation of ventilatory support, which was achieved by
decreasing the ventilatory rate. Recent in vitro experiments suggest that decreasing ventilatory rates may even play a role in
preventing ventilator-associated lung damage (25).
Several studies have documented improved pulmonary gas
exchange upon changeover from full to partial ventilatory support (11, 24, 26). Prospective randomized trials indicate that
the type of partial ventilatory support has little or no effect on
the efficiency of weaning from mechanically ventilation (22,
27). Previous investigations have compared different partial
ventilatory support modalities after prolonged mechanical
ventilation in patients whose pulmonary function and gas exchange had essentially recovered (22, 27). Furthermore, the
effects of full versus partial ventilatory support on cardiopulmonary function are difficult to evaluate on the basis of previous studies, because the modalities of mechanical ventilation
were changed during the investigations (22, 27). In our study,
the type of ventilatory support remained unchanged while the
presence of spontaneous breathing was controlled with sedation and neuromuscular blockade and
E remained constant. Therefore, our results should reflect essentially the effect of persisting spontaneous breathing, not that of a change in mechanical ventilatory support modality.
Early spontaneous breathing during APRV consistently resulted in improved
VA/
T and arterial blood oxygenation.
These observations are in agreement with experimental (5, 6)
and clinical (11, 24) findings that spontaneous breathing with
APRV improves arterial blood oxygenation by decreasing intrapulmonary shunting. Previous radiographic observations
have demonstrated that contractions of the diaphragm favor
distribution of ventilation to dependent, well-perfused lung
areas (8). Reduction of
VA/
T in the presence of an increasing lung compliance indicates that spontaneous breathing with
APRV improved the ventilation of initially nonventilated or
poorly ventilated lung areas. In accordance with our findings, diaphragmatic contractions have been shown to reduce the
size of atelectasis in dependent lung areas during general anesthesia (28). Spontaneous breathing should be associated
with an increase in transpulmonary pressure caused by diaphragmatic contractions, and should therefore effectively recruit atelectatic lung regions or prevent progressive alveolar
collapse in patients at risk for ARDS.
By contrast, full ventilatory support in anesthetized and
paralyzed patients with normal lung function has been shown
to result in atelectasis in dependent lung regions, which contributes considerabley to
VA/
T (29). In accord with these
observations (29), absence of spontaneous breathing during
mechanical ventilation, induced by deep sedation and neuromuscular blockade in our patients, promoted formation of
atelectasis, presumably by a cephalad shift of the diaphragm
and reflected by worsened lung compliance,
VA/
T, and arterial oxygenation. After 72 h of mechanical ventilation, spontaneous breathing with APRV improved but did not restore
gas exchange and lung mechanics.
Deep sedation with neuromuscular blockade is generally used to adapt patients to controlled mechanical ventilation (30). In a previous study we distinguished between the effects of sedation and neuromuscular blockade on gas exchange. Neuromuscular blockade did not affect gas exchange in patients with severe ARDS who had been rendered apneic by reducing their PaCO2 (11). Therefore, the use of neuromuscular blockade to guarantee controlled mechanical ventilation cannot entirely explain the changes in cardiopulmonary function observed with persisting spontaneous breathing during APRV. Sedation in our patients was titrated to suppress spontaneous breathing. Under this condition, midazolam and sufentanil inhibited respiratory muscle activity and should have reduced the tension of the diaphragm (31). The cephalad shift of the diaphragm caused by its reduced tension during deep sedation or anesthesia is not aggravated by neuromuscular blockade (32). In agreement with observations during anesthesia, even higher airway pressures during controlled mechanical ventilation cannot prevent the development of atelectasis and deterioration of gas exchange (33). This may explain the deterioration in gas exchange observed in our patients who received initial PCV with deep sedation. However, the results of our study do not allow us to precisely distinguish the effects on cardiopulmonary function of deep sedation from those of controlled mechanical ventilation.
In our patients, spontaneous breathing was associated with an increase in CI. This is in agreement with the concept that a decrease in intrathoracic pressure during spontaneous inspiration with APRV may improve venous return and CI (11, 34). The highest CI values and lowest required doses of vasopressors and positive inotropes in our study occurred with persisting spontaneous breathing during APRV. The smaller increase in CI found when spontaneous breathing occurred after a period of controlled mechanical ventilation may be attributed to higher airway pressure support levels or deeper sedation. End-expiratory lung hyperinflation cannot explain this cardiovascular finding, because PEEPi remained unchanged in both of our study groups. This indicates that during APRV, spontaneous respiratory activity may not decrease intrathoracic pressures sufficiently to entirely counteract the cardiovascular depression caused by higher airway pressures or deeper sedation.
Changes in CI caused by mechanical ventilation have been
reported to correlate positively with
VA/
T (35). In contrast, during spontaneous breathing with APRV, an increased CI
was associated with a smaller
VA/
T, an increased PaO2, and
a considerably higher DO2. This effect was less pronounced
when spontaneous breathing with APRV was allowed after 72 h
of controlled mechanical ventilation. In accordance with previous findings (11, 24, 36), total
O2 was not measurably altered by spontaneous breathing in our patients. The comparable total
O2 indicates appropriate sedation levels in both of
our study groups. An increased DO2 with unchanged
O2 resulted in an improved relationship between tissue oxygen supply and demand, as reflected by a significant decrease in O2ER, which also may have contributed to the higher PaO2 during
APRV with spontaneous breathing.
Primarily partial ventilatory support with APRV was consistently associated with a shorter duration of ventilatory support, intubation, and ICU stay. This presumably results from the improvement in cardiopulmonary function with persisting spontaneous breathing without excessive sedation. Previous investigations demonstrated that standardized weaning protocols allow early identification of patients for spontaneous breathing trials, and thereby reduce the duration of mechanical ventilation (22). Because identical protocols were used to discontinue ventilatory support in both of our study groups, our results suggest that persisting spontaneous breathing with APRV is efficient for reducing the duration of ventilatory support. Hsiang and coworkers reported that deep sedation and neuromuscular blockade in patients with head injury was associated with a higher incidence of pulmonary dysfunction and a prolonged ICU stay (37). Recently, Kress and coworkers (38) observed that daily interruption of sedative-drug infusions shortened the duration of ventilatory support and length of ICU stay. In accord with these findings, our results suggest that primarily spontaneous breathing with APRV avoided unnecessary deep sedation and thereby the reduced duration of ventilatory support and length of ICU stay. Because spontaneous breathing during APRV persisted only with less deep sedation, we cannot precisely distinguish the effects of sedation from those of spontaneous ventilation on duration of ventilatory support.
The results of this study show that partial ventilatory support with APRV, when used as a primary modality, allows reduction in sedation, contributes to improved arterial oxygenation, pulmonary compliance, and systemic blood flow, and is associated with a decreased duration of ventilatory support and ICU stay in patients at risk for ARDS. An initial period of controlled mechanical ventilation required unnecessary deep sedation and did not provide any advantage in cardiopulmonary function or clinical course.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Christian Putensen M.D., Department of Anesthesiology and Intensive Care Medicine, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. E-mail: putensen{at}uni-bonn.de
(Received in original form January 21, 2000 and in revised form August 17, 2000).
Acknowledgments: The authors wish to thank Prof. Göran Hedenstierna and Prof. Jukka Räsänen for their suggestions in reviewing this manuscript.
Supported by the Lorenz Boehler Trauma Foundation.
| |
References |
|---|
|
|
|---|
1. Gattinoni L, Bombino M, Pelosi P, Lissoni A, Pesenti A, Fumagalli R, Tagliabue M. Lung structure and function in different stages of severe adult respiratory distress syndrome. JAMA 1994; 271: 1772-1779 [Abstract].
2. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
3.
Amato MB,
Barbas CS,
Meddeiros DM,
Magaldi RB,
Schettino GP,
Lorenzi-Fiho G,
Kairalla RA,
Deheinzellin D,
Munzo C,
Oliveira R, et al
.
Effect of protective-ventilation strategy on mortality in the adult
respiratory distress syndrome.
N Engl J Med
1998;
338:
347-354
4. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 293-301 [Abstract].
5. Putensen C, Räsänen J, Lopez FA, Downs JB. Effect of interfacing between spontaneous breathing and mechanical cycles on the ventilation-perfusion distribution in canine lung injury. Anesthesiology 1994; 81: 921-930 [Medline].
6. Putensen C, Räsänen J, Lopez FA. Ventilation-perfusion distribution during mechanical ventilation with superimposed spontaneous breathing in canine lung injury. Am J Respir Crit Care Med 1994; 150: 101-108 [Abstract].
7. Weisman IM, Rinaldo JE, Rogers RM, Sanders MH. Intermittent mandatory ventilation. Am Rev Respir Dis 1983; 127: 641-647 [Medline].
8. Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974; 41: 242-255 [Medline].
9.
Baum M,
Benzer H,
Putensen C,
Koller W,
Putz G.
Biphasic positive
airway pressure (BIPAP)
a new form of augmented ventilation.
Anaesthesist
1989;
38:
452-458
[Medline].
10. Stock MC, Downs JB, Frolicher DA. Airway pressure release ventilation. Crit Care Med 1987; 15: 462-466 [Medline].
11.
Putensen C,
Mutz N,
Putensen-Himmer G,
Zinserling J.
Spontaneous
breathing during ventilatory support improves ventilation-perfusion
distributions in patients with acute respiratory distress syndrome.
Am
J Respir Crit Care Med
1999;
159:
1241-1248
12. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1994; 14: 187-196 .
13. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824 [Abstract].
14. Members of the American College of Chest Physician/Society of Critical Care Medicine. American College of Chest Physician/Society of Critical Care Medicine Consensus Conference Definition of sepsis and organ failure and guidelines for the use of inovative therapies in sepsis. Crit Care Med 1992;20:864-874.
15. Knaus WA, Draper EA, Wagner DP, Zimmermann JE. Prognosis in acute organ system failure. Ann Surg 1985; 11: 685-693 .
16. Le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, Mathieu D, Merceir P, Thomas R, Villers D. A simplified acute physiologic score for ICU patients. Crit Care Med 1984; 12: 975-977 [Medline].
17. Rossi A, Gottfried SB, Zocchi L, Higgs BD, Lennox S, Calverley PMA, Begin P, Grassino A, Milic-Emili J. Measurement of static compliance of the total respiratory system in patients with acute respiratory failure during mechanical ventilation: the effect of intrinsic positive end-expiratory pressure. Am Rev Respir Dis 1985; 131: 672-677 [Medline].
18. Amato MB, Barbas CS, Medeiros DM, Schettino G, Filho GL, Kairalla RA, Deheinzelin D, Morais C, Oliviera Fernandes E, Takagaki TY, et al. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med 1985;152:1835-1846.
19.
Putensen C,
Baum M,
Hörmann C.
Selecting ventilator settings according
to variables derived from the quasi-static pressure/volume relationship
in patients with acute lung injury.
Anesth Analg
1993;
77:
436-447
20. Roupie E, Dambrosio M, Servillo G, Mentec H. el Atrous S, Beydon L, Brun-Buisson C, Lemaire F, Brochard L. Titration of tidal volume and induced hypercapnia in acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 121-128 [Abstract].
21. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656-659 .
22.
Esteban A,
Frutos F,
Tobin MJ,
Alia I,
Solsona JF,
Valverdu I,
Fernandez R,
De La Cal MA,
Benito S,
Tomas R, et al
.
A comparison of four
methods of weaning patients from mechanical ventilation.
N Engl J
Med
1995;
332:
345-350
23. Goris RJ, Gimbrere JS, van Niekerk JL, Schoots FJ, Booy LH. Early osteosynthesis and prophylactic mechanical ventilation in the multitrauma patient. J Trauma 1982; 22: 895-903 [Medline].
24. Sydow M, Burchardi H, Ephraim E, Zielmann S, Crozier TA. Long-term effects of two different ventilatory modes on oxygenation in acute lung injury: comparison of airway pressure release ventilation and volume-controlled inverse ratio ventilation. Am J Respir Crit Care Med 1994; 149: 1550-1556 [Abstract].
25.
Hotchkiss JR,
Blanch L,
Murias G,
Adams AB,
Olson DA,
Wangensteen OD,
Leo PH,
Marini JJ.
Am J Respir Crit Care Med
2000;
161:
463-468
26.
Wolff G,
Brunner JX,
Grädel E.
Gas exchange during mechanical ventilation and spontaneous breathing.
Chest
1986;
90:
11-17
27. Brochard L, Rauss A, Benito S, Conti G, Mancebo J, Rekik N, Gaspereto A, Lemaire F. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 1994; 150: 896-903 [Abstract].
28. Hedenstierna G, Tokics L, Lundquist H, Andersson T, Strandberg A, Brismar B. Phrenic nerve stimulation during halothane anesthesia: effects of atelectasis. Anesthesiology 1994; 80: 751-760 [Medline].
29. Tokics L, Hedenstierna G, Strandberg A, Brismar B, Lundquist H. Lung collapse and gas exchange during general anesthesia: effects of spontaneous breathing, muscle paralysis, and positive end-expiratory pressure. Anesthesiology 1987; 66: 157-167 [Medline].
30. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. JAMA 1991; 266: 2870-2875 [Abstract].
31. Don HF, Wahba M, Cuadrado L, Kelkar K. The effects of anesthesia and 100 per cent oxygen on the functional residual capacity of the lungs. Anesthesiology 1970; 32: 521-529 [Medline].
32. Reber A, Nylund U, Hedenstierna G. Position and shape of the diaphragm: implications for atelectasis formation. Anaesthesia 1998; 53: 1054-1061 [Medline].
33.
Rothen HU,
Sporre B,
Engberg G,
Wegenius G,
Hedenstierna G.
Re-expansion of atelectasis during general anaesthesia: a computed tomography study.
Br J Anaesth
1993;
71:
788-795
34.
Downs JB,
Douglas ME,
Sanfelippo PM,
Stanford W,
Hodges MR.
Ventilatory pattern, intrapleural pressure, and cardiac output.
Anesth Analg
1997;
56:
88-96
35.
Lynch JP,
Mhyre JG,
Dantzker DR.
Influence of cardiac output on intrapulmonary shunt.
J Appl Physiol
1979;
46:
315-321
36.
Räsänen J,
Puhakka K,
Leijala M.
Spontaneous breathing and total
body oxygen consumption in children recovering from open-heart surgery.
Chest
1992;
101:
662-667
37. Hsiang JK, Chesnut RM, Crisp CB, Klauber MR, Blunt BA, Marshall LF. Early, routine paralysis for intracranial pressure control in severe head injury: is it necessary? Crit Care Med 1994; 22: 1471-1476 [Medline].
38.
Kress JP,
Pohlman AS,
O'Connor MF,
Hall JB.
Daily interruption of
sedative infusions in critical ill patients undergoing mechanical ventilation.
N Engl J Med
2000;
342:
1471-1477
This article has been cited by other articles:
![]() |
R. Hering, J. Zinserling, H. Wrigge, D. Varelmann, A. Berg, S. Kreyer, and C. Putensen Effects of Spontaneous Breathing During Airway Pressure Release Ventilation on Respiratory Work and Muscle Blood Flow in Experimental Lung Injury Chest, October 1, 2005; 128(4): 2991 - 2998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Isik, I. Kati, I. Bayram, and H. Ozbek A new agent for treatment of acute respiratory distress syndrome: thymoquinone. An experimental study in a rat model Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 301 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vassilakopoulos and B. J. Petrof Ventilator-induced Diaphragmatic Dysfunction Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 336 - 341. [Full Text] [PDF] |
||||
![]() |
L. Magnusson and D. R. Spahn New concepts of atelectasis during general anaesthesia Br. J. Anaesth., July 1, 2003; 91(1): 61 - 72. [Full Text] [PDF] |
||||
![]() |
N. M. Habashi, J. O'Connor, and M. McCunn Venilator Management and Criical Care Issues Following Cardiothoracic Trauma Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2002; 6(2): 127 - 147. [Abstract] [PDF] |
||||
![]() |
C. S. H. Sassoon, V. J. Caiozzo, A. Manka, and G. C. Sieck Altered diaphragm contractile properties with controlled mechanical ventilation J Appl Physiol, June 1, 2002; 92(6): 2585 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Critical Care Medicine in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 565 - 583. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |